bariatric surgery vs glp 1 Among patients who were eligible for metabolic and in a national sample in the US, prescriptions for semaglutide and tirzepatide increased dramatically from 2018 to 2025, whereas rates of metabolic Bariatric Surgery vs. GLP-1 Drugs

28, 2025, semaglutide (Ozempic) received FDA approval to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to cardiovascular disease (CVD) in adults with type 2 diabetes (T2DM) and chronic kidney disease (CKD)

DOI: 10.2337/db10-0474 Shaefer CF Jr et al (2015): User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Injectable curcumin compound

These side effects are important to consider when weighing the benefits of using Topamax for BED

Benefits of Choosing a Local Specialist In the era of telehealth, its tempting to rely on remote providers for convenience